Literature DB >> 19405787

Treatment strategies for Legionella infection.

M Luisa Pedro-Botet1, Victor L Yu.   

Abstract

Given the nonspecific clinical manifestations of Legionnaires' disease and the high mortality of untreated Legionnaires' disease, we recommend routine use of Legionella testing, especially the Legionella urinary antigen test, for all patients with community-acquired pneumonia. This includes patients with ambulatory pneumonia and hospitalized children. Legionella cultures should be more widely available, especially in hospitals where the drinking water is colonized with Legionella. Azithromycin or levofloxacin can be considered as first-line therapy. Other antibiotics including tetracyclines, tigecycline, other fluoroquinolones and other macrolides (especially clarithromycin) are also effective. The clinical response of quinolones may be somewhat more favorable compared to macrolides, but the outcome is similar. If the Legionnaires' disease is hospital-acquired, culturing of the hospital drinking water for Legionella is indicated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19405787     DOI: 10.1517/14656560902900820

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  14 in total

1.  Legionella feeleii serotype 2 pneumonia in a man with chronic lymphocytic leukemia: a challenging diagnosis.

Authors:  Marc O Siegel; Daniel P Fedorko; Steven K Drake; Leslie B Calhoun; Steven M Holland
Journal:  J Clin Microbiol       Date:  2010-03-31       Impact factor: 5.948

2.  In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.

Authors:  Takafumi Sato; Kazuhiro Tateda; Soichiro Kimura; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

3.  Legionellosis in Transplantation.

Authors:  Shobini Sivagnanam; Steven A Pergam
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

4.  Motor neuron disease mortality rates in U.S. states are associated with well water use.

Authors:  Gary G Schwartz; Marilyn G Klug
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-06-21       Impact factor: 4.092

5.  Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series.

Authors:  Stephanie Cargnelli; Jeff Powis; Jennifer L Y Tsang
Journal:  J Med Case Rep       Date:  2016-12-01

6.  A Proactive Environmental Approach for Preventing Legionellosis in Infants: Water Sampling and Antibiotic Resistance Monitoring, a 3-Years Survey Program.

Authors:  Ioanna Alexandropoulou; Theodoros Parasidis; Theocharis Konstantinidis; Maria Panopoulou; Theodoros C Constantinidis
Journal:  Healthcare (Basel)       Date:  2019-03-08

7.  Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes.

Authors:  Yehonatan Sharaby; Orna Nitzan; Ingrid Brettar; Manfred G Höfle; Avi Peretz; Malka Halpern
Journal:  Sci Rep       Date:  2019-04-16       Impact factor: 4.379

8.  Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.

Authors:  Lubana Shadoud; Iyad Almahmoud; Sophie Jarraud; Jérôme Etienne; Sylvie Larrat; Carole Schwebel; Jean-François Timsit; Dominique Schneider; Max Maurin
Journal:  EBioMedicine       Date:  2015-07-17       Impact factor: 8.143

9.  Tigecycline as a Second-Line Agent for Legionnaires' Disease in Severely Ill Patients.

Authors:  Deepika Slawek; Diana Altshuler; Yanina Dubrovskaya; Eddie Louie
Journal:  Open Forum Infect Dis       Date:  2017-10-07       Impact factor: 3.835

Review 10.  Disseminated extrapulmonary Legionella pneumophila infection presenting with panniculitis: case report and literature review.

Authors:  Maria N Chitasombat; Natta Ratchatanawin; Yingluck Visessiri
Journal:  BMC Infect Dis       Date:  2018-09-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.